Vice president quits as Egypt votes on constitution


CAIRO (Reuters) - Egypt's vice-president resigned on Saturday as Egyptians voted in a referendum that is expected to approve a new constitution that lays the foundations for the country's transition to democracy but will strip him of his role.


Authorities extended voting by four hours in the second and decisive round of the plebiscite on an Islamist-drafted constitution that the opposition has criticized as divisive and likely to cause more unrest.


Just hours before polls closed, Vice President Mahmoud Mekky announced his resignation, saying he wanted to quit last month but stayed on to help President Mohamed Mursi tackle a crisis that blew up when the Islamist leader assumed wide powers.


Mekky, a prominent judge who said he was uncomfortable in politics, disclosed earlier he had not been informed of Mursi's power grab. However, the timing of Mekky's move appeared linked to the fact there is no vice-presidential post under the draft constitution.


In a resignation letter, Mekky said that although he had held on in the post he had "realized for some time that the nature of political work did not suit my professional background as a judge".


Islamist supporters of Mursi say the charter is vital to move towards democracy, nearly two years after an Arab Spring revolt overthrew authoritarian ruler Hosni Mubarak. It will help restore stability needed to fix a struggling economy, they say.


But the opposition says the document is divisive and has accused Mursi of pushing through a text that favors his Islamist allies while ignoring the rights of Christians, who make up about 10 percent of the population, as well as women.


"I'm voting 'no' because Egypt can't be ruled by one faction," said Karim Nahas, 35, a stockbroker, heading to a polling station in Giza, a province included in this round of voting which covers parts of greater Cairo.


At another polling station, some voters said they were more interested in ending Egypt's long period of political instability than in the Islamist aspects of the charter.


"We have to extend our hands to Mursi to help fix the country," said Hisham Kamal, an accountant.


Queues formed at some polling stations around the country and voting was extended by four hours to 11 p.m. (2100 GMT).


Unofficial tallies are likely to emerge within hours of the close, but the referendum committee may not declare an official result for the two rounds until Monday, after hearing appeals.


CHEATING ALLEGED


As polling opened on Saturday, a coalition of Egyptian rights groups reported a number of alleged irregularities.


They said some polling stations had opened late, that Islamists urging a "yes" vote had illegally campaigned at some stations, and complained of irregularities in voter registration irregularities, including the listing of one dead person.


Last week's first round of voting gave a 57 percent vote in favour of the constitution, according to unofficial figures.


Analysts expect another "yes" on Saturday because the vote covers rural and other areas seen as having more Islamist sympathizers. Islamists may also be able to count on many Egyptians who are simply exhausted by two years of upheaval.


Among the provisions of the new basic law are a limit of two four-year presidential terms. It says the principles of sharia law remain the main source of legislation but adds an article to explain this further. It also says Islamic authorities will be consulted on sharia - a source of concern to Christians and other non-Muslims.


If the constitution is passed, a parliamentary election will be held in about two months. If not, an assembly will have to be set up to draft a new one.


After the first round of voting, the opposition said alleged abuses meant the first stage of the referendum should be re-run.


But the committee overseeing the two-stage vote said its investigations showed no major irregularities in voting on December 15, which covered about half of Egypt's 51 million voters.


MORE UNREST


Even if the charter is approved, the opposition say it is a recipe for trouble since it has not received sufficiently broad backing from the population. They say the result may go in Mursi's favour but it will not be a fair vote.


"I see more unrest," said Ahmed Said, head of the liberal Free Egyptians Party and a member of the National Salvation Front, an opposition coalition formed after Mursi expanded his powers on November 22 and then pushed the constitution to a vote.


Protesters accused the president of acting like a pharaoh, and he was forced to issue a second decree two weeks ago that amended a provision putting his decisions above legal challenge.


Said cited "serious violations" on the first day of voting, and said anger against Mursi and his Islamist allies was growing. "People are not going to accept the way they are dealing with the situation."


At least eight people were killed in protests outside the presidential palace in Cairo this month. Islamists and rivals clashed on Friday in the second biggest city of Alexandria, hurling stones at each other. Two buses were torched.


The head of the Muslim Brotherhood, an Islamist group that represents Mursi's power base, said the vote was an opportunity for Egypt to move on.


"After the constitution is settled by the people, the wheels in all areas will turn, even if there are differences here and there," the Brotherhood's supreme guide, Mohamed Badie, said as he went to vote in Beni Suef, south of Cairo.


"After choosing a constitution, all Egyptians will be moving in the same direction," he said.


The vote was staggered after many judges refused to supervise the ballot, meaning there were not enough to hold the referendum on a single day nationwide.


The first round was won by a slim enough margin to buttress opposition arguments that the text was divisive. Opponents who include liberals, leftists, Christians and more moderate-minded Muslims accuse Islamists of using religion to sway voters.


Islamists, who have won successive ballots since Mubarak's overthrow, albeit by narrowing margins, dismiss charges that they are exploiting religion and say the document reflects the will of a majority in the country where most people are Muslim.


(Additional reporting by Tamim Elyan; Writing by Edmund Blair and Giles Elgood; Editing by Mark Trevelyan and Jason Webb)



Read More..

PEOPLE Remembers the American Soldiers Killed in Afghanistan

With the exit from Iraq and the draw-down of troops in Afghanistan, the numbers of Americans killed continues to drop.

Still, loved ones are mourning 311 lost, and as of Dec. 17, the wars' toll since 2001 now stands at 6,656.

Edward Joseph Acosta, 21
Trevor Brandon Adkins, 21
Ahmed Kousay al-Taie, 46 Erica Paige Alecksen, 21
Tobias Christoph Alexander, 30
Joseph James Altmann, 27
Mabry James Anders, 21
Joshua Ryan Ashley, 23
Bradley Wayne Atwell, 27

Daniel Benjamin Bartle, 27
Jon-Luke Bateman, 22
Jonathan Batista, 22
Rayvon Battle Jr., 25
Taylor John Baune, 21
Jordan Logan Bear, 25
Clayton Ross Beauchamp, 21
Genaro Bedoy, 20
Bryan Richard Bell, 23
Russell Ryan Bell, 37
Jose Oscar Belmontes, 28
Kenneth Wade Bennett, 26
Keith David Benson, 27
Richard Liam Berry, 27
Robert John Billings, 30
Christopher James Birdwell, 25
Jeremie Shane Border, 28
Christopher David Bordoni, 21
Joshua Alan Born, 25
Michael Cean Braden, 31
Mikayla Anne Bragg, 21
John R. Brainard III, 26
Sean Edward Brazas, 26
Andrew Trevor Britton-Mihalo, 25
Michael John Brodsky, 33
Christopher L. Brown, 26
Daniel Joseph Brown, 27
Milton W. Brown, 28
Gregory Thomas Buckley, 21
Antonio Carlos Burnside, 31
Thomas Jefferson Butler IV, 25
Brandon Lucas Buttry, 19

Gerardo Campos, 23
Shane William Cantu, 20
Daniel Lewis Carlson, 21
Sean Patrick Carson, 32
Roberto Cazarez, 24
Julian Clement Chase, 22
Nicolas D. Checque, 28
Gregory Lamont Childs, 38
Bruce Kevin Clark, 43
Junot M. L. Cochilus, 34
Kenneth Eldren Cochran, 20
Keaton Grant Coffey, 22
Julian Lee Colvin, 21
Timothy John Conrad Jr., 22
Gregory Todd Copes, 36
Cesar Cortez, 24
Niall William Cotisears, 23

Joseph D’Augustine, 29
Johnathon Frank Davis, 20
Nathan Tyler Davis, 20
Coater Bernard Debose, 55
Michael Robert Demarsico II, 20
Anthony Joseph Denier, 26
Leroy Deronde III, 22
Nicholas Michael Dickhut, 23
Scott Edward Dickinson, 29
Alex Frank Domion, 21
Curtis Joseph Duarte, 22
Michael Stephen Duskin, 42
James Evan Dutton, 25
Edward Joe Dycus, 22

Kevin Richard Ebbert, 32
Jason Kyle Edens, 22
Brandon Forrest Eggleston, 29
Vincent James Ellis, 22
Darrel Lynn Enos, 36
Richard Allen Essex, 23
Bobby Lee Estle, 38
Kyler Lavon Estrada, 21

Joseph Henry Fankhauser, 30
Aaron Matthew Faust, 22
Mathew Gregory Fazzari, 25
Patrick Delaney Feeks, 28
Arronn David Fields, 27
Krystal Marie Fitts, 26
Joseph Fitzmorris, 31
Thomas Kent Fogarty, 30
Nicholas Charles Fredsti, 30

Vilmar Galarza Hernandez, 21
Luis Antonio Oliver Galbreath, 41
Jonathan William Gifford, 34
Theodore Matthew Glende, 23
Jonathan Alan Gollnitz, 28
Moises Jesus Gonzalez, 29
Brandon Dwayne Goodine, 20
Brittany Bria Gordon, 24
Brett Edward Gornewicz, 27
Walter David Gray, 38
Kevin James Griffin, 45
Samuel Mark Griffith, 36
Jesse James Grindey, 30
Dustin Dean Gross, 19
Raul Madrigal Guerra, 37
Michael J. Guillory, 28

Ryan Preston Hall, 30
Carl Erik Hammar, 24
Shawn Thomas Hannon, 44
John Eric Hansen, 41
Justin Michael Hansen, 26
Jeremy Franklin Hardison, 23
Zachary Hayden Hargrove, 32
Aaron Arthur Henderson, 33
Alex Hernandez III, 21
Pernell Johnnie Herrera, 33
Channing Bo Hicks, 24
Darrion Terrell Hicks, 21
Tanner Stone Higgins, 23
Terence John Hildner, 49
Hunter Dalton Hogan, 21
Eric Scott Holman, 39
Patricia Lee Horne, 20
Brian Daniel Hornsby, 37
Justin Louis Horsley, 21
John Patrick Huling, 25

Francis Dee Imlay Jr., 31
Aaron Dale Istre, 37

Kedith Lamont Jacobs Jr., 21
Sean Robert Jacobs, 23
Jamie Darrell Jarboe, 27
Ryan Paul Jayne, 22
Ryan Jeschke, 31
David Andrew Johnson, 24
Donna Rae Johnson, 29
Nicholas Scott Johnson, 27
Payton Alexander Jones, 19
James Austin Justice, 21

Ramon Taisakan Kaipat, 22
Matthew Geoffrey Kantor, 22
Andrew James Keller, 22
Thomas Elliott Kennedy, 35
Kurt William Kern, 24
Richard James Kessler Jr., 47
Michael Joseph Knapp, 28
Jabraun Steven Knox, 23
Noah Mark Korte, 29
Suresh Niranjan Aba Krause, 29

Jarrod Allen Lallier, 20
Todd William Lambka, 25
Matthew John Leach, 29
Dick Alson Lee Jr., 31
Brian Jeffery Leonhardt, 21
Joseph Michael Lilly, 25
Darren M. Linde, 41
Daniel Lee Linnabary II, 23
Kevin E. Lipari, 39
Roberto Loeza Jr., 28
John Darin Loftis, 44
Joseph Daniel Logan, 22
Jesus Jonathan Lopez, 22
Conner Thomas Lowry, 24
Bryant Jordan Luxmore, 25

Bruce Andrew MacFarlane, 46
Thomas Raymond MacPherson, 26
Matthew Patrick Manoukian, 29
Robert Joseph Marchanti II, 48
Justin Cameron Marquez, 25
Chase Stone Marta, 24
Ethan Jacob Martin, 22
Alex Martinez, 21
Robert Anthony Massarelli, 32
Erik Nathaniel May, 26
Kyle Brenton McClain, 25
Philip Daine McGeath, 25
Nathan Ronald McHone, 29
Allen Robert McKenna Jr., 28
Barett Wambli McNabb, 33
Richard Lewis McNulty III, 22
John David Meador II, 36
Dale Wayne Means, 23
Kashif Mohammed Memon, 31
Michael Joseph Metcalf, 22
Daniel Thomas Metcalfe, 29
Jonathan Matthew Metzger, 32
Cale Clyde Miller, 23
Eugene Clifton Mills III, 21
Christopher Michael Monahan Jr., 25
Jose Luis Montenegro Jr., 31
Osbrany Montes De Oca, 20
Cody Otho Moosman, 24
Travis Alan Morgado, 25
Christopher E. Mosko, 28
Sky Russell Mote, 27
Christopher Lee Muniz, 24

Dustin Paul Napier, 20
Juan Pantoja Navarro, 23
Benjamin Harold Neal, 21
James Dominic Nehl, 37
Joshua Nathaniel Nelson, 22
Sapuro Brightley Nena, 25
David Paul Nowaczyk, 32
Israel Paul Nuanes, 38

Nicholas Henry Olivas, 20
Tyler J. Orgaard, 20
Kyle Bruce Osborn, 26
Jesse Aaron Ozbat, 28

Scott Patrick Pace, 39
Joshua Cole Pairsh, 29
Michael Jeremy Palacio, 23
Alejandro Jose Pardo, 21
Christopher Alexander Patterson, 20
Brandon Robert Pepper, 31
Sergio Eduardo Perez, 21
Trevor Adam Pinnick, 20
Benjamin Carlos Pleitez, 25
William Compton Poling Jr., 42
Paris Shawn Pough, 40
Alexander George Povilaitis Jr., 47
Stephen Chase Prasnicki, 24
John Castle Pratt, 51
Daniel Joseph Price, 27
Scott Eugene Pruitt, 38
Michael Wayne Pyron, 30

Christopher Keith Raible, 40
Thalia Suzanne Ramirez, 28
Ryan Davis Rawl, 30
Clovis Tim Ray, 34
Jerry Don Reed II, 30
Chad Robert Regelin, 24
Nicholas J. Reid, 26
Kevin James Reinhard, 25
Jose Joel Reyes, 24
Jeffrey Leon Rice, 24
Joseph Alvin Richardson, 23
Travis William Riddick, 40
Jeffrey James Rieck, 46
Michael Eugene Ristau, 25
Richard Anthony Rivera Jr., 20
Daquane Demetris Rivers, 21
Dion Rashun Roberts, 25
Leonard Robinson, 29
Daniel Anthony Rodriguez, 28
Jose Rodriguez, 22
Kyle Robert Rookey, 23
Adam Corey Ross, 19
Nicholas Jan Rozanski, 36
Clinton Keith Ruiz, 22
David E. Rylander, 23

Brenden Neal Salazar, 20
Christian Riley Sannicolas, 20
Ryan James Savard, 29
Philip Channing Sipe Schiller, 21
Joseph Lee Schiro, 27
Jonathan Philip Schmidt, 28
Julian Seiji Scholten, 26
Jacob Michael Schwallie, 22
Matthew Scott Schwartz, 34
Matthew Ryan Seidler, 24
Ricardo Seija, 31
Anthony Ramon Servin, 22
Dean Russell Shaffer, 23
Christopher Greg Singer, 23
Matthew Steven Sitton, 26
James Lyn Skalberg Jr., 25
Tyler James Smith, 24
Orion Nelson Sparks, 29
William Chapman Stacey, 23
Cameron James Stambaugh, 20
Trevor Jovanne Stanley, 22
Camella Marchett Steedley, 31
Riley Gene Stephens, 39
Steven Prince Stevens II, 23
Matthew Henrick Stiltz, 26
Jesse Wade Stites, 23
Michael Joseph Strachota, 28
Sean Patrick Sullivan, 40
Billy Albert Sutton, 42
Steven Gene Sutton, 24
Jason Michael Swindle, 24

Abraham Tarwoe, 25
Robert Joseph Tauteris Jr., 44
Tofiga Joshua Tautolo, 23
David Wayne Taylor, 20
Nicholas Andrew Taylor, 20
Alec Robert Terwiske, 21
Matthew Bradford Thomas, 30
Alejo Rene Thompson, 30
Joel Del Mundo Tiu, 48
Louis Ramon Torres, 23
Jon Ross Townsend, 19
Gregory Ray Trent, 38
Nelson D. Trent, 37
Neil Isaac Turner, 21

Jalfred David Vaquerano, 20
Manuel Joseph Vasquez, 22
Jorge Luis Velasquez, 35
Dain Taylor Venne, 29
Don Cayetano Viray, 25
Paul Clarke Voelke, 36

Brian Lloyd Walker, 25
Jonathan Patrick Walsh, 28
Eric Dean Warren, 23
David John Warsen, 27
Samuel Thomas Watts, 20
Dennis Paul Weichel Jr., 29
Jeffrey Lee White Jr., 21
Nicholas Schade Whitlock, 29
Justin Michael Whitmire, 20
Ronald Herbert Wildrick Jr., 30
Justin James Wilkens, 26
Clarence Williams III, 23
David Vincent Williams, 24
Eric Edward Williams, 27
Wesley R. Williams, 25
Ryan James Wilson, 26
Shane Gregory Wilson, 20
Wade Daniel Wilson, 22
William Robert Wilson III, 27
Jessica Marie Wing, 42
Benjamin Brian Wise, 34
Joshua Eli Witsman, 23
Chris John Workman, 33
Sterling William Wyatt, 21

Read More..

Predicting who's at risk for violence isn't easy


CHICAGO (AP) — It happened after Columbine, Virginia Tech, Aurora, Colo., and now Sandy Hook: People figure there surely were signs of impending violence. But experts say predicting who will be the next mass shooter is virtually impossible — partly because as commonplace as these calamities seem, they are relatively rare crimes.


Still, a combination of risk factors in troubled kids or adults including drug use and easy access to guns can increase the likelihood of violence, experts say.


But warning signs "only become crystal clear in the aftermath, said James Alan Fox, a Northeastern University criminology professor who has studied and written about mass killings.


"They're yellow flags. They only become red flags once the blood is spilled," he said.


Whether 20-year-old Adam Lanza, who used his mother's guns to kill her and then 20 children and six adults at their Connecticut school, made any hints about his plans isn't publicly known.


Fox said that sometimes, in the days, weeks or months preceding their crimes, mass murderers voice threats, or hints, either verbally or in writing, things like "'don't come to school tomorrow,'" or "'they're going to be sorry for mistreating me.'" Some prepare by target practicing, and plan their clothing "as well as their arsenal." (Police said Lanza went to shooting ranges with his mother in the past but not in the last six months.)


Although words might indicate a grudge, they don't necessarily mean violence will follow. And, of course, most who threaten never act, Fox said.


Even so, experts say threats of violence from troubled teens and young adults should be taken seriously and parents should attempt to get them a mental health evaluation and treatment if needed.


"In general, the police are unlikely to be able to do anything unless and until a crime has been committed," said Dr. Paul Appelbaum, a Columbia University professor of psychiatry, medicine and law. "Calling the police to confront a troubled teen has often led to tragedy."


The American Academy of Child & Adolescent Psychiatry says violent behavior should not be dismissed as "just a phase they're going through."


In a guidelines for families, the academy lists several risk factors for violence, including:


—Previous violent or aggressive behavior


—Being a victim of physical or sexual abuse


—Guns in the home


—Use of drugs or alcohol


—Brain damage from a head injury


Those with several of these risk factors should be evaluated by a mental health expert if they also show certain behaviors, including intense anger, frequent temper outbursts, extreme irritability or impulsiveness, the academy says. They may be more likely than others to become violent, although that doesn't mean they're at risk for the kind of violence that happened in Newtown, Conn.


Lanza, the Connecticut shooter, was socially withdrawn and awkward, and has been said to have had Asperger's disorder, a mild form of autism that has no clear connection with violence.


Autism experts and advocacy groups have complained that Asperger's is being unfairly blamed for the shootings, and say people with the disorder are much more likely to be victims of bullying and violence by others.


According to a research review published this year in Annals of General Psychiatry, most people with Asperger's who commit violent crimes have serious, often undiagnosed mental problems. That includes bipolar disorder, depression and personality disorders. It's not publicly known if Lanza had any of these, which in severe cases can include delusions and other psychotic symptoms.


Young adulthood is when psychotic illnesses typically emerge, and Appelbaum said there are several signs that a troubled teen or young adult might be heading in that direction: isolating themselves from friends and peers, spending long periods alone in their rooms, plummeting grades if they're still in school and expressing disturbing thoughts or fears that others are trying to hurt them.


Appelbaum said the most agonizing calls he gets are from parents whose children are descending into severe mental illness but who deny they are sick and refuse to go for treatment.


And in the case of adults, forcing them into treatment is difficult and dependent on laws that vary by state.


All states have laws that allow some form of court-ordered treatment, typically in a hospital for people considered a danger to themselves or others. Connecticut is among a handful with no option for court-ordered treatment in a less restrictive community setting, said Kristina Ragosta, an attorney with the Treatment Advocacy Center, a national group that advocates better access to mental health treatment.


Lanza's medical records haven't been publicly disclosed and authorities haven't said if it is known what type of treatment his family may have sought for him. Lanza killed himself at the school.


Jennifer Hoff of Mission Viejo, Calif. has a 19-year-old bipolar son who has had hallucinations, delusions and violent behavior for years. When he was younger and threatened to harm himself, she'd call 911 and leave the door unlocked for paramedics, who'd take him to a hospital for inpatient mental care.


Now that he's an adult, she said he has refused medication, left home, and authorities have indicated he can't be forced into treatment unless he harms himself — or commits a violent crime and is imprisoned. Hoff thinks prison is where he's headed — he's in jail, charged in an unarmed bank robbery.


___


Online:


American Academy of Child & Adolescent Psychiatry: http://www.aacap.org


___


AP Medical Writer Lindsey Tanner can be reached at http://www.twitter.com/LindseyTanner


Read More..

Wall Street Week Ahead: A lump of coal for "Fiscal Cliff-mas"

NEW YORK (Reuters) - Wall Street traders are going to have to pack their tablets and work computers in their holiday luggage after all.


A traditionally quiet week could become hellish for traders as politicians in Washington are likely to fall short of an agreement to deal with $600 billion in tax hikes and spending cuts due to kick in early next year. Many economists forecast that this "fiscal cliff" will push the economy into recession.


Thursday's debacle in the U.S. House of Representatives, where Speaker John Boehner failed to secure passage of his own bill that was meant to pressure President Obama and Senate Democrats, only added to worry that the protracted budget talks will stretch into 2013.


Still, the market remains resilient. Friday's decline on Wall Street, triggered by Boehner's fiasco, was not enough to prevent the S&P 500 from posting its best week in four.


"The markets have been sort of taking this in stride," said Sandy Lincoln, chief market strategist at BMO Asset Management U.S. in Chicago, which has about $38 billion in assets under management.


"The markets still basically believe that something will be done," he said.


If something happens next week, it will come in a short time frame. Markets will be open for a half-day on Christmas Eve, when Congress will not be in session, and will close on Tuesday for Christmas. Wall Street will resume regular stock trading on Wednesday, but volume is expected to be light throughout the rest of the week with scores of market participants away on a holiday break.


For the week, the three major U.S. stock indexes posted gains, with the Dow Jones industrial average <.dji> up 0.4 percent, the S&P 500 <.spx> up 1.2 percent and the Nasdaq Composite Index <.ixic> up 1.7 percent.


Stocks also have booked solid gains for the year so far, with just five trading sessions left in 2012: The Dow has advanced 8 percent, while the S&P 500 has climbed 13.7 percent and the Nasdaq has jumped 16 percent.


IT COULD GET A LITTLE CRAZY


Equity volumes are expected to fall sharply next week. Last year, daily volume on each of the last five trading days dropped on average by about 49 percent, compared with the rest of 2011 - to just over 4 billion shares a day exchanging hands on the New York Stock Exchange, the Nasdaq and NYSE MKT in the final five sessions of the year from a 2011 daily average of 7.9 billion.


If the trend repeats, low volumes could generate a spike in volatility as traders keep track of any advance in the cliff talks in Washington.


"I'm guessing it's going to be a low volume week. There's not a whole lot other than the fiscal cliff that is going to continue to take the headlines," said Joe Bell, senior equity analyst at Schaeffer's Investment Research, in Cincinnati.


"A lot of people already have a foot out the door, and with the possibility of some market-moving news, you get the possibility of increased volatility."


Economic data would have to be way off the mark to move markets next week. But if the recent trend of better-than-expected economic data holds, stocks will have strong fundamental support that could prevent selling from getting overextended even as the fiscal cliff negotiations grind along.


Small and mid-cap stocks have outperformed their larger peers in the last couple of months, indicating a shift in investor sentiment toward the U.S. economy. The S&P MidCap 400 Index <.mid> overcame a technical level by confirming its close above 1,000 for a second week.


"We view the outperformance of the mid-caps and the break of that level as a strong sign for the overall market," Schaeffer's Bell said.


"Whenever you have flight to risk, it shows investors are beginning to have more of a risk appetite."


Evidence of that shift could be a spike in shares in the defense sector, expected to take a hit as defense spending is a key component of the budget talks.


The PHLX defense sector index <.dfx> hit a historic high on Thursday, and far outperformed the market on Friday with a dip of just 0.26 percent, while the three major U.S. stock indexes finished the day down about 1 percent.


Following a half-day on Wall Street on Monday ahead of the Christmas holiday, Wednesday will bring the S&P/Case-Shiller Home Price Index. It is expected to show a ninth-straight month of gains.


U.S. jobless claims on Thursday are seen roughly in line with the previous week's level, with the forecast at 360,000 new filings for unemployment insurance, compared with the previous week's 361,000.


(Wall St Week Ahead runs every Friday. Questions or comments on this column can be emailed to: rodrigo.campos(at)thomsonreuters.com)


(Reporting by Rodrigo Campos; Additional reporting by Chuck Mikolajczak; Editing by Jan Paschal)



Read More..

Italy PM Monti resigns, elections likely in February


ROME (Reuters) - Italian Prime Minister Mario Monti tendered his resignation to the president on Friday after 13 months in office, opening the way to a highly uncertain national election in February.


The former European commissioner, appointed to lead an unelected government to save Italy from financial crisis a year ago, has kept his own political plans a closely guarded secret but he has faced growing pressure to seek a second term.


President Giorgio Napolitano is expected to dissolve parliament in the next few days and has already indicated that the most likely date for the election is February 24.


In an unexpected move, Napolitano said he would hold consultations with political leaders from all the main parties on Saturday to discuss the next steps. In the meantime Monti will continue in a caretaker capacity.


European leaders including German Chancellor Angela Merkel and European Commission President Jose Manuel Barroso have called for Monti's economic reform agenda to continue but Italy's two main parties have said he should stay out of the race.


Monti, who handed in his resignation during a brief meeting at the presidential palace shortly after parliament approved his government's 2013 budget, will hold a news conference on Sunday at which he is expected clarify his intentions.


Ordinary Italians are weary of repeated tax hikes and spending cuts and opinion polls offer little evidence that they are ready to give Monti a second term. A survey this week showed 61 percent saying he should not stand.


Whether he runs or not, his legacy will loom over an election which will be fought out over the painful measures he has introduced to try to rein in Italy's huge public debt and revive its stagnant economy.


His resignation came a couple of months before the end of his term, after his technocrat government lost the support of Silvio Berlusconi's centre-right People of Freedom (PDL) party in parliament earlier this month.


Speculation is swirling over Monti's next moves. These could include outlining policy recommendations, endorsing a centrist alliance committed to his reform agenda or even standing as a candidate in the election himself.


The centre-left Democratic Party (PD) has held a strong lead in the polls for months but a centrist alliance led by Monti could gain enough support in the Senate to force the PD to seek a coalition deal which could help shape the economic agenda.


BERLUSCONI IN WINGS


Senior figures from the alliance, including both the UDC party, which is close to the Roman Catholic Church, and a new group founded by Ferrari sports car chairman Luca di Montezemolo, have been hoping to gain Monti's backing.


He has not said clearly whether he intends to run, but he has dropped heavy hints he will continue to push a reform agenda that has the backing of both Italy's business community and its European partners.


The PD has promised to stick to the deficit reduction targets Monti has agreed with the European Union and says it will maintain the broad course he has set while putting more emphasis on reviving growth.


Berlusconi's return to the political arena has added to the already considerable uncertainty about the centre-right's intentions and increased the likelihood of a messy and potentially bitter election campaign.


The billionaire media tycoon has fluctuated between attacking the government's "Germano-centric" austerity policies and promising to stand aside if Monti agrees to lead the centre right, but now appears to have settled on an anti-Monti line.


He has pledged to cut taxes and scrap a hated housing tax which Monti imposed. He has also sounded a stridently anti-German line which has at times echoed the tone of the populist 5-Star Movement headed by maverick comic Beppe Grillo.


The PD and the PDL, both of which supported Monti's technocrat government in parliament, have made it clear they would not be happy if he ran against them and there have been foretastes of the kind of attacks he can expect.


Former centre-left prime minister Massimo D'Alema said in an interview last week that it would be "morally questionable" for Monti to run against the PD, which backed all of his reforms and which has pledged to maintain his pledges to European partners.


Berlusconi who has mounted an intensive media campaign in the past few days, echoed that criticism this week, saying Monti risked losing the credibility he has won over the past year and becoming a "little political figure".


(Additional reporting by Gavin Jones, Massimiliano Di Giorgio and Paolo Biondi; Writing by Gavin Jones and James Mackenzie; Editing by Michael Roddy)



Read More..

Zoë Saldana's Early Christmas Gift: A New Rescue Dog!















12/21/2012 at 02:30 PM EST







Zoe Saldana and her new dog Mugsy


Courtesy Zoe Saldana. Inset: Tony DiMaio/startraks


Christmas has come a few days early for Zoë Saldana.

The actress has received a gift in the form of a little white rescue pup that she adopted just days before the holiday.

"Meet Mugsy!!! Rescued her last week – my best friend named her – ha! She's adorable and super smart," Saldana Tweeted Thursday, with a photo of the wiry-haired pooch sitting in the passenger's seat of a car.

Perhaps spending timing with her boyfriend Bradley Cooper's dog Charlotte is what persuaded the The Words star to adopt a furry friend of her own. Saldana spent Thanksgiving walking outdoors with the white chow/retriever mix, who is definitely one of the leading ladies in Cooper's life.

"She has to like my dogs," The Hangover star told PEOPLE in 2009 of what he looks for in a potential girlfriend. "My dogs and I come in a package."

Here's hoping Charlotte and Mugsy have already hit it off!

Read More..

AP IMPACT: Big Pharma cashes in on HGH abuse


A federal crackdown on illicit foreign supplies of human growth hormone has failed to stop rampant misuse, and instead has driven record sales of the drug by some of the world's biggest pharmaceutical companies, an Associated Press investigation shows.


The crackdown, which began in 2006, reduced the illegal flow of unregulated supplies from China, India and Mexico.


But since then, Big Pharma has been satisfying the steady desires of U.S. users and abusers, including many who take the drug in the false hope of delaying the effects of aging.


From 2005 to 2011, inflation-adjusted sales of HGH were up 69 percent, according to an AP analysis of pharmaceutical company data collected by the research firm IMS Health. Sales of the average prescription drug rose just 12 percent in that same period.


___


EDITOR'S NOTE — Whether for athletics or age, Americans from teenagers to baby boomers are trying to get an edge by illegally using anabolic steroids and human growth hormone, despite well-documented risks. This is the second of a two-part series.


___


Unlike other prescription drugs, HGH may be prescribed only for specific uses. U.S. sales are limited by law to treat a rare growth defect in children and a handful of uncommon conditions like short bowel syndrome or Prader-Willi syndrome, a congenital disease that causes reduced muscle tone and a lack of hormones in sex glands.


The AP analysis, supplemented by interviews with experts, shows too many sales and too many prescriptions for the number of people known to be suffering from those ailments. At least half of last year's sales likely went to patients not legally allowed to get the drug. And U.S. pharmacies processed nearly double the expected number of prescriptions.


Peddled as an elixir of life capable of turning middle-aged bodies into lean machines, HGH — a synthesized form of the growth hormone made naturally by the human pituitary gland — winds up in the eager hands of affluent, aging users who hope to slow or even reverse the aging process.


Experts say these folks don't need the drug, and may be harmed by it. The supposed fountain-of-youth medicine can cause enlargement of breast tissue, carpal tunnel syndrome and swelling of hands and feet. Ironically, it also can contribute to aging ailments like heart disease and Type 2 diabetes.


Others in the medical establishment also are taking a fat piece of the profits — doctors who fudge prescriptions, as well as pharmacists and distributors who are content to look the other way. HGH also is sold directly without prescriptions, as new-age snake oil, to patients at anti-aging clinics that operate more like automated drug mills.


Years of raids, sports scandals and media attention haven't stopped major drugmakers from selling a whopping $1.4 billion worth of HGH in the U.S. last year. That's more than industry-wide annual gross sales for penicillin or prescription allergy medicine. Anti-aging HGH regimens vary greatly, with a yearly cost typically ranging from $6,000 to $12,000 for three to six self-injections per week.


Across the U.S., the medication is often dispensed through prescriptions based on improper diagnoses, carefully crafted to exploit wiggle room in the law restricting use of HGH, the AP found.


HGH is often promoted on the Internet with the same kind of before-and-after photos found in miracle diet ads, along with wildly hyped claims of rapid muscle growth, loss of fat, greater vigor, and other exaggerated benefits to adults far beyond their physical prime. Sales also are driven by the personal endorsement of celebrities such as actress Suzanne Somers.


Pharmacies that once risked prosecution for using unauthorized, foreign HGH — improperly labeled as raw pharmaceutical ingredients and smuggled across the border — now simply dispense name brands, often for the same banned uses. And usually with impunity.


Eight companies have been granted permission to market HGH by the U.S. Food and Drug Administration, which reviews the benefits and risks of new drug products. By contrast, three companies are approved for the diabetes drug insulin.


The No. 1 maker, Roche subsidiary Genentech, had nearly $400 million in HGH sales in the U.S. last year, up an inflation-adjusted two-thirds from 2005. Pfizer and Eli Lilly were second and third with $300 million and $220 million in sales, respectively, according to IMS Health. Pfizer now gets more revenue from its HGH brand, Genotropin, than from Zoloft, its well-known depression medicine that lost patent protection.


On their face, the numbers make no sense to the recognized hormone doctors known as endocrinologists who provide legitimate HGH treatment to a small number of patients.


Endocrinologists estimate there are fewer than 45,000 U.S. patients who might legitimately take HGH. They would be expected to use roughly 180,000 prescriptions or refills each year, given that typical patients get three months' worth of HGH at a time, according to doctors and distributors.


Yet U.S. pharmacies last year supplied almost twice that much HGH — 340,000 orders — according to AP's analysis of IMS Health data.


While doctors say more than 90 percent of legitimate patients are children with stunted growth, 40 percent of 442 U.S. side-effect cases tied to HGH over the last year involved people age 18 or older, according to an AP analysis of FDA data. The average adult's age in those cases was 53, far beyond the prime age for sports. The oldest patients were in their 80s.


Some of these medical records even give explicit hints of use to combat aging, justifying treatment with reasons like fatigue, bone thinning and "off-label," which means treatment of an unapproved condition


Even Medicare, the government health program for older Americans, allowed 22,169 HGH prescriptions in 2010, a five-year increase of 78 percent, according to data released by the Centers for Medicare and Medicaid Services in response to an AP public records request.


"There's no question: a lot gets out," said hormone specialist Dr. Mark Molitch of Northwestern University, who helped write medical standards meant to limit HGH treatment to legitimate patients.


And those figures don't include HGH sold directly by doctors without prescriptions at scores of anti-aging medical practices and clinics around the country. Those numbers could only be tallied by drug makers, who have declined to say how many patients they supply and for what conditions.


First marketed in 1985 for children with stunted growth, HGH was soon misappropriated by adults intent on exploiting its modest muscle- and bone-building qualities. Congress limited HGH distribution to the handful of rare conditions in an extraordinary 1990 law, overriding the generally unrestricted right of doctors to prescribe medicines as they see fit.


Despite the law, illicit HGH spread around the sports world in the 1990s, making deep inroads into bodybuilding, college athletics, and professional leagues from baseball to cycling. The even larger banned market among older adults has flourished more recently.


FDA regulations ban the sale of HGH as an anti-aging drug. In fact, since 1990, prescribing it for things like weight loss and strength conditioning has been punishable by 5 to 10 years in prison.


Steve Kleppe, of Scottsdale, Ariz., a restaurant entrepreneur who has taken HGH for almost 15 years to keep feeling young, said he noticed a price jump of about 25 percent after the block on imports. He now buys HGH directly from a doctor at an annual cost of about $8,000 for himself and the same amount for his wife.


Many older patients go for HGH treatment to scores of anti-aging practices and clinics heavily concentrated in retirement states like Florida, Nevada, Arizona and California.


These sites are affiliated with hundreds of doctors who are rarely endocrinologists. Instead, many tout certification by the American Board of Anti-Aging and Regenerative Medicine, though the medical establishment does not recognize the group's bona fides.


The clinics offer personalized programs of "age management" to business executives, affluent retirees, and other patients of means, sometimes coupled with the amenities of a vacation resort. The operations insist there are few, if any, side effects from HGH. Mainstream medical authorities say otherwise.


A 2007 review of 31 medical studies showed swelling in half of HGH patients, with joint pain or diabetes in more than a fifth. A French study of about 7,000 people who took HGH as children found a 30 percent higher risk of death from causes like bone tumors and stroke, stirring a health advisory from U.S. authorities.


For proof that the drug works, marketers turn to images like the memorable one of pot-bellied septuagenarian Dr. Jeffry Life, supposedly transformed into a ripped hulk of himself by his own program available at the upscale Las Vegas-based Cenegenics Elite Health. (He declined to be interviewed.)


These promoters of HGH say there is a connection between the drop-off in growth hormone levels through adulthood and the physical decline that begins in late middle age. Replace the hormone, they say, and the aging process slows.


"It's an easy ruse. People equate hormones with youth," said Dr. Tom Perls, a leading industry critic who does aging research at Boston University. "It's a marketing dream come true."


___


Associated Press Writer David B. Caruso reported from New York and AP National Writer Jeff Donn reported from Plymouth, Mass. AP Writer Troy Thibodeaux provided data analysis assistance from New Orleans.


___


AP's interactive on the HGH investigation: http://hosted.ap.org/interactives/2012/hgh


___


The AP National Investigative Team can be reached at investigate(at)ap.org


EDITOR'S NOTE _ Whether for athletics or age, Americans from teenagers to baby boomers are trying to get an edge by illegally using anabolic steroids and human growth hormone, despite well-documented risks. This is the second of a two-part series.


Read More..

Wall Street sinks as "fiscal cliff" fears escalate

NEW YORK (Reuters) - U.S. stocks slid on Friday after a Republican plan to avoid the "fiscal cliff" failed to gain support on Thursday night, shrinking hopes that a deal would be reached before the new year.


Trading was volatile as investors lost confidence in the prospect of a deal between the White House and Republicans. Lower volume ahead of the Christmas and New Year's holidays exaggerated market swings. The CBOE Volatility Index <.vix> or VIX, the market's favored anxiety measure, rose 5 percent to 18.56, but was off the day's high.


Republican House Speaker John Boehner failed to garner enough votes even from his own party to pass his "Plan B" tax bill late on Thursday. This was the latest setback in negotiations to avoid $600 billion in tax hikes and spending cuts that some say could tip the U.S. economy into recession.


"The failure with Plan B was disappointing, if not terribly surprising, but now there's a real lack of clarity about what will happen, and markets hate that," said Mike Hennessy, managing director of investments for Morgan Creek in Chapel Hill, North Carolina.


The day's biggest loser on the New York Stock Exchange was Herbalife , which dropped for an eighth straight session. Investor Bill Ackman recently ramped up his campaign against the company. Herbalife skidded 19 percent to $27.25 and has lost more than 35 percent this week.


Plan B, which called for tax increases on those who earn $1 million or more a year, was not going to pass the Democratic-led Senate or win acceptance from the White House anyway. But it exposed the reality that it will be difficult to get Republican support for the more expansive tax increases that President Barack Obama has urged.


Still, the declines of about 1 percent in the three major U.S. stock indexes suggest that investors do not believe the economy will be unduly damaged by the absence of a deal, said Mark Lehmann, president of JMP Securities, in San Francisco.


"You could have easily woken up today and seen the market down 300 or 400 points, and everyone would have said, 'That's telling you this is really dire,'" Lehmann said.


"I think if you get into mid-January and (the talks) keep going like this, you get worried, but I don't think we're going to get there."


Banking shares, which outperform in times of economic expansion and have led the market on signs of progress with resolving the fiscal impasse, led declines. Citigroup Inc fell 2 percent to $39.35, while Bank of America slid 2.3 percent to $11.25. The KBW Banks index <.bkx> lost 1.4 percent.


The Dow Jones industrial average <.dji> dropped 142.29 points, or 1.07 percent, to 13,169.43. The Standard & Poor's 500 Index <.spx> dropped 15.69 points, or 1.09 percent, to 1,428.00. The Nasdaq Composite Index <.ixic> dropped 39.23 points, or 1.29 percent, to 3,011.15.


Even with the day's declines, the S&P 500 is up nearly 1 percent for the week and about 13 percent for the year.


The day's round of data indicated the economy was surprisingly resilient in November; consumer spending rose by the most in three years and a gauge of business investment jumped.


But separate data showed consumer sentiment slumped in December. The S&P Retail Index <.spxrt> fell 1.4 percent.


U.S.-listed shares of Research in Motion sank 21 percent to $11.09 after the Canadian company, known as the BlackBerry maker, reported its first-ever decline in its subscriber numbers on Thursday alongside a new fee structure for its high-margin services segment.


(Additional reporting by Ryan Vlastelica and Leah Schnurr; Editing by Bernadette Baum and Jan Paschal)



Read More..

Acer will beat Google to market with its own $99 tablet









Title Post: Acer will beat Google to market with its own $99 tablet
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

The Best Viral Videos of 2012















12/20/2012 at 02:05 PM EST



Everybody danced like a galloping horse, thanks to "Gangnam Style."

Everyone sang "Call Me Maybe" – even Barack Obama. (Well, sort of.)

And everyone wondered why Zooey Deschanel asked, "Siri, is that rain?" when she was standing by a window in an iPhone commercial.

These and more were the viral videos of the year – the clips you posted on Facebook, shared on Twitter and clustered around your coworker's computer to watch over and over.

Want to watch them all again? Ain't nobody got time for that (as Sweet Brown said this year).

Thanks to Videogum, you can watch the best of the best, this retrospective mash-up of the funniest, creepiest, weirdest Internet videos of the year.

And yes, there are news anchors embarrassing themselves. It wouldn't be the Internet if there weren't!

Read More..